Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Short Interest Update

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) was the recipient of a significant drop in short interest in July. As of July 31st, there was short interest totaling 4,819 shares, a drop of 53.1% from the July 15th total of 10,281 shares. Approximately 0.9% of the shares of the company are short sold. Based on an average daily volume of 105,236 shares, the short-interest ratio is currently 0.0 days.

Defiance Daily Target 2X Long LMND ETF Stock Performance

Shares of LMNX stock traded down $0.17 during trading on Friday, reaching $8.88. 17,570 shares of the company’s stock traded hands, compared to its average volume of 48,024. The firm’s 50-day moving average is $13.80 and its 200 day moving average is $17.18. The company has a market capitalization of $4.88 million, a P/E ratio of 17.41 and a beta of -18.70. Defiance Daily Target 2X Long LMND ETF has a 1 year low of $6.90 and a 1 year high of $55.00. The company has a current ratio of 8.37, a quick ratio of 6.08 and a debt-to-equity ratio of 0.52.

Defiance Daily Target 2X Long LMND ETF Company Profile

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays.